Nymox Pharmaceutical Corp año OPV
¿Qué es el año OPV de Nymox Pharmaceutical Corp?
El año OPV de Nymox Pharmaceutical Corp es 2015
¿Cuál es la definición de año OPV?
La oferta pública inicial es un tipo de oferta pública en la cual las acciones de una compañía generalmente se venden a inversionistas institucionales que, a su vez, venden al público en general, en una bolsa de valores, por primera vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
año OPV de compañías en Sector Health Care en NASDAQ en comparadas con Nymox Pharmaceutical Corp
¿Qué hace Nymox Pharmaceutical Corp?
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
Empresas con año opv similar a Nymox Pharmaceutical Corp
- Global Brands tiene año OPV de 2014
- Antibe Therapeutics tiene año OPV de 2014
- ArcelorMittal 5.50% Mandatorily tiene año OPV de 2014
- The Toronto-Dominion Bank PFD SER 5 tiene año OPV de 2014
- WisdomTree EURO STOXX Banks 3x Daily Leveraged tiene año OPV de 2014
- Horizons Us Lrg Cap Eqty Cvrd C tiene año OPV de 2014
- Nymox Pharmaceutical Corp tiene año OPV de 2015
- Larsen & Toubro Infotech tiene año OPV de 2016
- Escape Hunt plc tiene año OPV de 2016
- SiteOne Landscape Supply Inc tiene año OPV de 2016
- Lloyds Steels Industries tiene año OPV de 2016
- Liberty Media tiene año OPV de 2016
- Atlanta Braves Inc tiene año OPV de 2016